Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

New Gene Therapy Reverses Heart Failure in Large Animal Model Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart ...

Bayer’s AskBio unit has reported the first clinical data for its congestive heart failure gene therapy ... the current standard of care does not reverse the trajectory of the disease to ultimate ...

Bayer’s AskBio gene therapy unit has started recruiting patients into a phase 2 trial of its AB-1002 candidate for congestive heart failure (CHF), buoyed by encouraging data from a first-in ...

Nuevocor Pte. Ltd. has closed a $45 million series B, enabling it to move lead gene therapy NVC-001 into the clinic in the ...

A four-year-old boy with a life-threatening immune disease ... gene therapy. After the successful gene therapy, which has been sponsored by Rocket Pharmaceuticals, Eisa was able to have his heart ...

A research team has developed and safely delivered a personalized gene editing therapy to treat an infant with a life-threatening, incurable genetic disease. The infant, who was diagnosed with the ...

Nuevocor is developing a one-time gene therapy for heart failure patients. Inovio taking on Covid again, almost 3 years after abandoning vaccine CEO says biotech firm is on path to $1B in revenue ...

Nuevocor Pte. Ltd. has closed a $45 million series B, enabling it to move lead gene therapy NVC-001 into the clinic in the treatment of an inherited form of cardiomyopathy. BioWorld BioWorld Asia ...